SI
CELG

Stephens Inc’s Celgene Corp CELG Stock Holding History

Stephens Inc’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,185
Closed -$1.41M – 1225
2019
Q3 		$1.41M Sell
14,185
-2,575
-15% -$245K 0.03% 473
2019
Q2 		$1.55M Sell
16,760
-4,982
-23% -$473K 0.04% 459
2019
Q1 		$2.05M Sell
21,742
-11,169
-34% -$977K 0.05% 392
2018
Q4 		$2.11M Buy
32,911
+1,860
+6% +$137K 0.06% 342
2018
Q3 		$2.78M Buy
+31,051
New +$2.74M 0.07% 327
2017
Q3 		– Sell
-55,201
Closed -$7.17M – 945
2017
Q2 		$7.17M Buy
55,201
+6,587
+14% +$807K 0.25% 86
2017
Q1 		$6.05M Sell
48,614
-5,307
-10% -$635K 0.22% 99
2016
Q4 		$6.24M Buy
53,921
+1,796
+3% +$200K 0.25% 79
2016
Q3 		$5.45M Sell
52,125
-192
-0.4% -$20.8K 0.24% 85
2016
Q2 		$5.16M Sell
52,317
-4,159
-7% -$430K 0.23% 95
2016
Q1 		$5.65M Buy
56,476
+12,474
+28% +$1.28M 0.28% 71
2015
Q4 		$5.27M Buy
44,002
+3,125
+8% +$362K 0.26% 84
2015
Q3 		$4.42M Buy
40,877
+2,358
+6% +$293K 0.23% 93
2015
Q2 		$4.46M Sell
38,519
-528
-1% -$60.4K 0.2% 104
2015
Q1 		$4.5M Sell
39,047
-1,187
-3% -$142K 0.21% 114
2014
Q4 		$4.5M Buy
40,234
+5,844
+17% +$616K 0.21% 109
2014
Q3 		$3.26M Sell
34,390
-2,906
-8% -$262K 0.16% 155
2014
Q2 		$3.2M Sell
37,296
-470
-1% -$35.7K 0.16% 155
2014
Q1 		$2.64M Buy
37,766
+3,258
+9% +$258K 0.14% 178
2013
Q4 		$2.92M Buy
34,508
+896
+3% +$70.9K 0.14% 155
2013
Q3 		$2.59M Buy
33,612
+4,122
+14% +$289K 0.14% 155
2013
Q2 		$1.73M Buy
+29,490
New +$1.77M 0.1% 191

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Stephens Inc's CELG Position: Q4 2019 in Review

Stephens Inc sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 14,185 shares — an estimated $1.41M sold.

Stephens Inc first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $7.17M in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Stephens Inc reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Stephens Inc sold 14,185 Celgene Corp shares in Q4 2019, an estimated $1.41M.
  • Stephens Inc first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • Stephens Inc's Celgene Corp position peaked at $7.17M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Stephens Inc's 13F filing for Q4 2019, filed 14 Feb 2020.